Cerenis Therapeutics has gathered EUR 42.1m in its second round of institutional funding. TVM Capital and OrbiMed of the US join the existing investors, all of which renewed their commitments.
Company has raised €20m so far over two funding rounds
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy